NeuroPace NPCE
NASDAQ NPCE
$13.98 -0.66 (-4.48%)
At close: Aug 20, 2026 · 12:08 PM UTC

NeuroPace (NPCE) EBT Margin (2020 - 2026)

NeuroPace (NPCE) posted quarterly EBT Margin of 99.54% for Q1 2026, down 7044.0% year-over-year from 1.43% in Q1 2025, and down 921.87% quarter-over-quarter from 9.74% in Q4 2025.

NeuroPace (NPCE) EBT Margin (2020 - 2026) Analysis & Trends

NeuroPace's EBT Margin history runs 7 years deep, the most recent figure standing at 99.54% for Q1 2026.

  • In Q1 2026, EBT Margin fell 7044.0% year-over-year to 99.54%; the TTM figure through Mar 2026 stood at 51.75% (down 1926.0% YoY), while the FY2025 annual figure was 36.04%, up 8515.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 99.54%, down from 9.74% in the prior quarter.
  • The five-year high for EBT Margin was 9.74% in Q4 2025, with the low at 123.58% in Q2 2022.
  • The 5-year median for EBT Margin is 49.76% (2024), against an average of 58.63%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 7308 bps in 2022, then surged 7266 bps in 2023.
  • NeuroPace's EBT Margin stood at 86.01% in 2022, then soared by 84 bps to 13.35% in 2023, then slumped by 161 bps to 34.84% in 2024, then surged by 72 bps to 9.74% in 2025, then tumbled by 922 bps to 99.54% in 2026.
  • Business Quant data shows NPCE's EBT Margin at 99.54% in Q1 2026, 9.74% in Q4 2025, and 18.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 12.10%
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn 23.74%
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn 18.70%
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 19.48%
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn 29.86%
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn 24.27%
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn 13.09%
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn 8.91%
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn 18.32%
10 NeuroPace 477.46 Mn 425.76 Mn 18.91 Mn -26.98%

Historic Data

Download Data
DateValue
Jun 30, 2026 -110.82%
Mar 31, 2026 -99.54%
Dec 31, 2025 -9.74%
Sep 30, 2025 -18.22%
Jun 30, 2025 -93.38%
Mar 31, 2025 -29.10%
Dec 31, 2024 -34.84%
Sep 30, 2024 -27.01%
Jun 30, 2024 -39.82%
Mar 31, 2024 -49.76%
Dec 31, 2023 -13.35%
Sep 30, 2023 -44.88%
Jun 30, 2023 -56.00%
Mar 31, 2023 -66.04%
Dec 31, 2022 -86.01%
Sep 30, 2022 -104.71%
Jun 30, 2022 -123.58%
Mar 31, 2022 -100.74%
Dec 31, 2021 -97.65%
Sep 30, 2021 -76.73%